• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human ALS2CR11 Polyclonal Antibody

The antibody against C2CD6 was raised in rabbit using the Fusion protein of Human ALS2CR11 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

ADC-30960A

The antibody against C2CD6 was raised in rabbit using the Fusion protein of Human ALS2CR11 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-30960A ClonalityPolyclonal
Host SpeciesRabbitTarget NameC2CD6
Target SynonymsC2CD6 antibody; ALS2CR11C2 calcium-dependent domain-containing protein 6 antibody; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein antibodyFormLiquid
Species ReactivityHuman, MouseIsotypeIgG
Storage Buffer0.05% NaN3, 40% Glycerol., pH7.4 PBSPurification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionFusion protein of Human ALS2CR11Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ53TS8
Background Information
  • Uniprot Id

    Q53TS8

  • Target Species

    Human

  • Target Name

    C2CD6

  • Target Full Name

    Cation channel sperm-associated targeting subunit tau

  • Target Synonyms

    C2CD6; ALS2CR11C2 calcium-dependent domain-containing protein 6; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein

Inquire Rabbit anti-Human ALS2CR11 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification